Anna Mae E. Diehl,Gregory A. Michelotti,Mariana V. Machado,Sally A. Kornbluth,Erika Segear-Johnson,Kelly R. Lindblom
申请号：
US15664556
公开号：
US20170326199A1
申请日:
2017.07.31
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Methods and compositions for treatment of obesity, insulin resistance, hyperinsulinemia, type 2 diabetes mellitus, dyslipidemia, and nonalcoholic fatty liver disease are discloses. The methods and compositions relate to inhibition of caspase-2.
